Emil Samara

Title: Emil Samara: Innovator in Cancer Treatment

Introduction

Emil Samara is a notable inventor based in Danville, CA (US). He has made significant contributions to the field of cancer treatment through his innovative methods. His work focuses on developing effective treatments for various types of solid tumors and leukemias.

Latest Patents

Emil Samara holds 1 patent for his invention titled "Methods of treating cancer and related methods." This patent details methods for treating cancer using a specific compound, 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one. The methods are particularly effective for treating solid tumors or leukemias, including prostate, colorectal, breast, multiple myeloma, pancreatic, small cell carcinoma, acute myelogenous leukemia, chronic myelogenous leukemia, and myelo-proliferative disease. Additionally, the patent provides methods for measuring the amount of the compound and determining a metabolic profile.

Career Highlights

Emil Samara is currently employed at Novartis Vaccines & Diagnostics, GmbH, where he continues to advance his research in cancer treatment. His work at this esteemed company allows him to collaborate with other experts in the field and contribute to groundbreaking medical advancements.

Collaborations

Some of Emil's coworkers include Alison Hannah and Eric Harwood. Their collaboration fosters a dynamic environment for innovation and research in cancer therapies.

Conclusion

Emil Samara's contributions to cancer treatment through his patented methods highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer therapies, benefiting patients worldwide.